Food and Drug Administration
Institutional Review Board
Radiation Safety Review
The FHCRC/Cancer Consortium IRB Website provides guidance and requirements for radiation safety review for FHCRC and Cancer Consortium studies along with key contact information for the radiation safety departments at each of the Cancer Consortium sites.
Research Group Review
Over the past year, Dr. Paul Martin has worked with Consortium leadership to formalize the process of prioritizing clinical trials within Research Groups. As of December 1, 2013, a preliminary evaluation by the appropriate Research Group will be required prior to SRC review. All new clinical trials subject to SRC review should be formally evaluated during a regularly convened meeting of the Research Group. Read More »